Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Boehringer Ingelheim
McKinsey
Johnson and Johnson
Deloitte
Citi
Chubb
Merck
McKesson

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020771

« Back to Dashboard

NDA 020771 describes DETROL, which is a drug marketed by Pharmacia And Upjohn and is included in two NDAs. It is available from three suppliers. There are three patents protecting this drug and two Paragraph IV challenges. Additional details are available on the DETROL profile page.

The generic ingredient in DETROL is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
Summary for 020771
Tradename:DETROL
Applicant:Pharmacia And Upjohn
Ingredient:tolterodine tartrate
Patents:0
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020771
Medical Subject Heading (MeSH) Categories for 020771
Suppliers and Packaging for NDA: 020771
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DETROL tolterodine tartrate TABLET;ORAL 020771 NDA Pharmacia and Upjohn Company LLC 0009-4541 N 0009-4541-02
DETROL tolterodine tartrate TABLET;ORAL 020771 NDA Pharmacia and Upjohn Company LLC 0009-4544 N 0009-4544-02

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Mar 25, 1998TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Mar 25, 1998TE:ABRLD:Yes

Expired US Patents for NDA 020771

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-001 Mar 25, 1998 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Medtronic
McKinsey
Healthtrust
Boehringer Ingelheim
Fish and Richardson
QuintilesIMS
Accenture
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.